Related Experiment Video

Updated: Jun 17, 2026

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
07:56

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development

Published on: January 26, 2018

Myocardin functions as an effective inducer of growth arrest and differentiation in human uterine leiomyosarcoma

Yasunori Kimura1, Tsuyoshi Morita, Ken'ichiro Hayashi

  • 1Department of Neuroscience, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.

Cancer Research
|January 14, 2010
PubMed

Insights

Downregulation of myocardin, a key regulator, in uterine leiomyosarcoma reduces p21 expression, promoting cell proliferation. Restoring myocardin may offer a therapeutic strategy for this cancer.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Myocardin is a crucial transcriptional regulator for smooth and cardiac muscle development.
  • Myocardin expression is significantly reduced in human uterine leiomyosarcoma cells.

Purpose of the Study:

  • To investigate the role of myocardin in uterine leiomyosarcoma.
  • To elucidate the mechanism by which myocardin affects cell proliferation and its potential as a therapeutic target.

Main Methods:

  • Restoration of myocardin expression in leiomyosarcoma cells.
  • Analysis of smooth muscle marker proteins and actin fiber formation.
  • Assays for cell proliferation, p21 expression, and p21 promoter activity.
  • Chromatin immunoprecipitation and DNA-protein binding assays.
  • Immunohistochemical analysis of leiomyosarcoma and normal smooth muscle tissues.

Main Results:

  • Restoring myocardin reexpressed smooth muscle markers and improved actin structure.
  • Myocardin increased p21 expression, inhibiting cell cycle G(1)-S transition and reducing proliferation.
  • Myocardin enhanced p21 promoter activity via interaction with SRF at the CArG box.
  • Lower levels of myocardin and p21 were observed in leiomyosarcoma compared to normal tissue.

Conclusions:

  • Downregulation of myocardin contributes to cell cycle progression in leiomyosarcoma by reducing p21 expression.
  • Myocardin's role in regulating p21 suggests it is a potential therapeutic target for uterine leiomyosarcoma.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...